Loading...
Loading...
Among the 6 tracked institutional investors we monitor, TVRD (TVARDI THERAPEUTICS INC) is held with a combined value of $5.92M across 1,711,623 shares. The largest holder is Slate Path Capital LP with a position worth $2.24M (0.03% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 4 funds reduced their position.
Total Institutional Value
$5.92M
Total Shares Held
1,711,623
Institutional Holders
6
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | Slate Path Capital LP | $2.24M | 0.03% | - |
| 2 | VANGUARD GROUP INC | $1.83M | 0.00% | New |
| 3 | BlackRock, Inc. | $1.23M | 0.00% | -0.7% |
| 4 | STATE STREET CORP | $309.19K | 0.00% | -15.8% |
| 5 | RENAISSANCE TECHNOLOGIES LLC | $292.88K | 0.00% | -11.9% |
| 6 | FMR LLC | $16.78K | 0.00% | -20.0% |
As of the latest SEC 13F filings, Slate Path Capital LP is the largest institutional holder of TVRD with a position worth $2.24M, representing 0.03% of their portfolio. In total, 6 institutional investors hold TVRD with a combined value of $5.92M.
In the most recent quarter, 1 fund opened a new position in TVRD. Additionally, 4 reduced their positions.
Institutional investors hold $5.92M worth of TVRD stock across 6 positions. The largest institutional holder is Slate Path Capital LP with $2.24M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For TVRD, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their TVRD positions.